APP and Alzheimer disease: The export of FOXO3a from the nucleus can also lead to a reduction in the expression of the Rhodopsin‐associated protein kinase 1 (ROCK1) gene and the promotion of the activity of the nonamyloidogenic APP processing pathway, which is beneficial for reducing Aβ accumulation in AD.31